GCCL Completes Proactive Development of Biosimilar Clinical Trial Analysis Methods, Providing Customized Analysis Services through Enhanced R&D Capabilities

Newly established R&D division this year is expected to provide full-scale in-house R&D in addition to clinical sample analysis Including blockbuster drugs such as ‘Keytruda’ and ‘Yervoy’, GCCL offers tailored clinical trial analysis services for biosimilar development YONGIN, South…